Umberger Traci S 4

What Happened

• Traci S. Umberger, General Counsel and Chief Administrative Officer of Kestra Medical Technologies, reported the acquisition of 58,832 shares on July 15, 2026. The Form 4 shows the shares as an award/acquisition at $0.00 (no cash paid) and was filed on July 17, 2026.

Key Details

• Transaction date and type: 2026-07-15 — Award/acquisition (code A) of 58,832 shares at $0.00.
• Filing date: 2026-07-17 (reported in the Form 4). This appears to be timely reporting of the July 15 transaction.
• Shares owned after transaction: Not reported in this filing.
• Footnote: The shares represent common stock earned from performance-based RSUs (PSUs) granted July 17, 2025; 100% of the PSUs vested on July 15, 2026 based on achievement of specified performance goals (Footnote F1).
• Remarks: Insiders role listed as General Counsel and Chief Administrative Officer.

Context

• These were performance-based restricted stock units that vested (i.e., converted to common shares) rather than an open-market purchase or sale. The filing lists an acquisition value of $0.00 because the shares were delivered upon vesting; the filing does not state the market value realized. Awards and vesting are typically part of executive compensation and do not, by themselves, indicate a personal buy or sell decision.